MiRNA-145 increases therapeutic sensibility to gemcitabine treatment of pancreatic adenocarcinoma cells.
about
MiRNA-145 increases therapeutic sensibility to gemcitabine treatment of pancreatic adenocarcinoma cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MiRNA-145 increases therapeuti ...... ncreatic adenocarcinoma cells.
@en
MiRNA-145 increases therapeuti ...... ncreatic adenocarcinoma cells.
@nl
type
label
MiRNA-145 increases therapeuti ...... ncreatic adenocarcinoma cells.
@en
MiRNA-145 increases therapeuti ...... ncreatic adenocarcinoma cells.
@nl
prefLabel
MiRNA-145 increases therapeuti ...... ncreatic adenocarcinoma cells.
@en
MiRNA-145 increases therapeuti ...... ncreatic adenocarcinoma cells.
@nl
P2093
P2860
P356
P1433
P1476
MiRNA-145 increases therapeuti ...... ncreatic adenocarcinoma cells.
@en
P2093
Qiu-Dan Chen
Yiyang Wen
Zhu-Mei Shi
P2860
P304
70857-70868
P356
10.18632/ONCOTARGET.12268
P407
P577
2016-09-27T00:00:00Z